EPO and leukemia: In order to test our hypothesis to use B19V NS1 to kill leukemia cells, we transduced UT7/Epo-S1 cells with Ad5F11P-GFP (as a control) and Ad5F11p-B19NS1-GFP at an MOI of 100, respectively, to ensure over 90% of the cells were transduced.